Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease

Alzheimer's disease (AD) is characterized by, among other things, dementia and a decline in cognitive performance. In AD, dementia has neurodegenerative features and starts with mild cognitive impairment (MCI). Research indicates that apoptosis and neuronal loss occur in AD, in which oxidative...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of molecular sciences 2024-08, Vol.25 (16), p.8982
Hauptverfasser:	Flieger, Jolanta, Forma, Alicja, Flieger, Wojciech, Flieger, Michał, Gawlik, Piotr J, Dzierżyński, Eliasz, Maciejewski, Ryszard, Teresiński, Grzegorz, Baj, Jacek
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - drug therapy Alzheimer Disease - metabolism Alzheimer Disease - prevention & control Alzheimer's disease Animals Antioxidants - pharmacology Antioxidants - therapeutic use Apoptosis Brain research Carotenoids Carotenoids - pharmacology Carotenoids - therapeutic use Cognitive Dysfunction - drug therapy Cognitive Dysfunction - metabolism Cognitive Dysfunction - prevention & control Diet Dietary Supplements Disease prevention Flavonoids Functional foods & nutraceuticals Humans Lipid peroxidation Memory Nervous system Neuroprotective Agents - pharmacology Neuroprotective Agents - therapeutic use Oxidative stress Oxidative Stress - drug effects Pathogenesis Peptides Physiology Phytochemicals Polyphenols Proteins Review Sulfide compounds
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!